Can Diffusion Tensor Imaging (DTI) of the Optic Ways Contributes to Predict the 6 Months Prognosis of Optic Neuritis (ON)?
NCT ID: NCT03570385
Last Updated: 2022-11-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2017-12-04
2022-06-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy
NCT04451265
Linking Optic Nerve MRI and the Retinal Axonal Loss After Optic Neuritis
NCT03651362
RESting-state Functional MRI in Patients With Optic Neuritis for ANticipation of reCovEry
NCT04448938
Dynamic Contrast-Enhanced Magnetic Resonance Imaging Analysis for Prognosis of Intracranial Dissecting Aneurysm With Intramural Hematoma After Endovascular Treatment
NCT03940859
Diffusion Magnetic Resonance Imaging (dMRI) in the Early Evaluation of Brain White Matter Diseases
NCT07108712
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient with Optic Neuritis
MRI
MRI in diffusion tensor (DTI : Diffusion Tensor Imaging)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI
MRI in diffusion tensor (DTI : Diffusion Tensor Imaging)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinically suspected optic neuritis defined as a sudden decrease of the visual acuity and/or a damage to the field of vision and/or a defect of the colour vision and/or retro-orbital pain with a relative afferent pupillary defect (except if the optic neuropathy is bilateral or symmetrical), in the absence of a severe retinal macular pathology, and in the absence of a toxic or iatrogenic intake (ethambutol, vfend)
* Clinical optic neuritis duration \< 15 days
* First episode of an inflammatory ON
* No corticosteroids in the month before
* Indication to a corticosteroid therapy at high dose to cure the felt symptomatology
* Retinal nerve fibre layer (RNFL) thickness upper 75 µm at initial stage
* Isolated ON, multiple sclerosis or NMO (Neuro Myelitis Optica) - SD (Spectrum Disorder) context
* Having signed informed consent for participating in the study
Exclusion Criteria
* Cardiac pacemaker or defibrillator implant
* Neurosurgical clips
* Cochlear implants
* Intra-orbital or encephalic foreign bodies
* Stents implanted since less than 4 weeks and osteosynthesis equipment implanted since less than 6 weeks
* Claustrophobia
* Persons subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty
* Eye examination suggests a pre-existing eye abnormality that could affect the visual function (amblyopia, strong myopia…)
* Pregnant or breastfeeding women
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rennes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Rennes
Rennes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
35RC17_8828_DTI et NOI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.